Literature DB >> 14732294

Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012.

Andreas Daiber1, Michael August, Stephan Baldus, Maria Wendt, Matthias Oelze, Karsten Sydow, Andrei L Kleschyov, Thomas Munzel.   

Abstract

In the present study we sought to determine the ability of the chemiluminescence dye 8-amino-5-chloro-7-phenylpyridol[3,4-d]pyridazine-1,4-(2H,3H)dione sodium salt (L-012) to detect superoxide in different biological systems. In human whole blood or isolated leukocytes, the sensitivity of the luminol analogue L-012 to detect superoxide was higher as compared with luminol, lucigenin, coelenterazine, and the fluorescence dye dihydroethidine. In isolated leukocytes as well as aortic rings from control (New Zealand White) and hyperlipidemic (Watanabe heritable hyperlipidemic) rabbits, L-012-enhanced chemiluminescence was successful in detecting differences in superoxide formation under basal conditions and on stimulation with the direct activator of protein kinase C, phorbol 12,13-dibutyrate (PDBu). The effects of PDBu were abrogated by gliotoxin and inhibitors of protein kinase C such as chelerythrine, identifying NAD(P)H oxidase as the significant superoxide source. Experiments using electron paramagnetic resonance and the spin trap 5-diethoxyphosphoryl-5-methyl-1-pyrroline-N-oxide revealed that in contrast to lucigenin, L-012 is not subject to redox cycling. These findings indicate that L-012-enhanced chemiluminescence represents a sensitive and reliable probe to detect superoxide in whole blood, inflammatory cells, and vascular tissue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732294     DOI: 10.1016/j.freeradbiomed.2003.10.012

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  55 in total

1.  Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice.

Authors:  Sebastian Steven; Kerstin Jurk; Maximilian Kopp; Swenja Kröller-Schön; Yuliya Mikhed; Kathrin Schwierczek; Siyer Roohani; Fatemeh Kashani; Matthias Oelze; Thomas Klein; Sergey Tokalov; Sven Danckwardt; Susanne Strand; Philip Wenzel; Thomas Münzel; Andreas Daiber
Journal:  Br J Pharmacol       Date:  2016-08-21       Impact factor: 8.739

2.  α1AMP-activated protein kinase mediates vascular protective effects of exercise.

Authors:  Swenja Kröller-Schön; Thomas Jansen; Felix Hauptmann; Andrea Schüler; Tjebo Heeren; Michael Hausding; Matthias Oelze; Benoit Viollet; John F Keaney; Philip Wenzel; Andreas Daiber; Thomas Münzel; Eberhard Schulz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04-26       Impact factor: 8.311

3.  Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models.

Authors:  Swenja Kröller-Schön; Sebastian Steven; Sabine Kossmann; Alexander Scholz; Steffen Daub; Matthias Oelze; Ning Xia; Michael Hausding; Yuliya Mikhed; Elena Zinssius; Michael Mader; Paul Stamm; Nicolai Treiber; Karin Scharffetter-Kochanek; Huige Li; Eberhard Schulz; Philip Wenzel; Thomas Münzel; Andreas Daiber
Journal:  Antioxid Redox Signal       Date:  2013-08-17       Impact factor: 8.401

4.  NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes.

Authors:  Téni G Ebrahimian; Christophe Heymes; Dong You; Olivier Blanc-Brude; Barend Mees; Ludovic Waeckel; Micheline Duriez; José Vilar; Ralph P Brandes; Bernard I Levy; Ajay M Shah; Jean-Sébastien Silvestre
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

5.  Recent Developments in the Probes and Assays for Measurement of the Activity of NADPH Oxidases.

Authors:  Jacek Zielonka; Micael Hardy; Radosław Michalski; Adam Sikora; Monika Zielonka; Gang Cheng; Olivier Ouari; Radosław Podsiadły; Balaraman Kalyanaraman
Journal:  Cell Biochem Biophys       Date:  2017-06-29       Impact factor: 2.194

6.  Nitric oxide reduces NADPH oxidase 5 (Nox5) activity by reversible S-nitrosylation.

Authors:  Jin Qian; Feng Chen; Yevgeniy Kovalenkov; Deepesh Pandey; M Arthur Moseley; Matthew W Foster; Stephen M Black; Richard C Venema; David W Stepp; David J R Fulton
Journal:  Free Radic Biol Med       Date:  2012-03-01       Impact factor: 7.376

7.  Stimulatory TSH-Receptor Antibodies and Oxidative Stress in Graves Disease.

Authors:  Tanja Diana; Andreas Daiber; Matthias Oelze; Susanne Neumann; Paul D Olivo; Michael Kanitz; Paul Stamm; George J Kahaly
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

8.  Bridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors.

Authors:  Eugenia Cifuentes-Pagano; Jaideep Saha; Gábor Csányi; Imad Al Ghouleh; Sanghamitra Sahoo; Andrés Rodríguez; Peter Wipf; Patrick J Pagano; Erin M Skoda
Journal:  Medchemcomm       Date:  2013-07       Impact factor: 3.597

9.  Comparative pharmacology of chemically distinct NADPH oxidase inhibitors.

Authors:  S Wind; K Beuerlein; T Eucker; H Müller; P Scheurer; M E Armitage; H Ho; H H H W Schmidt; K Wingler
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

10.  Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats.

Authors:  Hanke Mollnau; Matthias Oelze; Elena Zinßius; Michael Hausding; Zhixiong Wu; Maike Knorr; Jasmin Ghaemi Kerahrodi; Swenja Kröller-Schön; Thomas Jansen; Christine Teutsch; Carolyn Foster; Huige Li; Philip Wenzel; Eberhard Schulz; Thomas Münzel; Andreas Daiber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-02-27       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.